Navigation Links
Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies
Date:4/21/2009

xposed PS, anti-PS antibodies have the potential to promote dendritic cell maturation in the body and thereby stimulate a more effective immune response."

The fully human PS-targeting antibodies in these studies were developed through Peregrine's collaboration with Affitech A/S. The study by Dr. Huang, et al. was partly supported by the Gillson Longenbaugh and Meredith D. Chesler Foundations.

Peregrine president and CEO Steven King commented, "It is noteworthy that these studies were primarily conducted using our new fully human antibodies, which could serve as the basis for the next generation of anti-PS therapies. Our PS-targeting antibody platform now includes several promising antibodies in preclinical evaluation that vary in their binding profile and in their specific immunomodulatory activity. The unique functional characteristics of these different antibodies open the door to new product candidates and extended applications for our anti-PS technology. We are more encouraged than ever that our anti-PS platform has very broad potential, and we look forward to further development of our growing preclinical pipeline of PS-targeting candidates both through internal efforts and collaborations with partners."

About Peregrine's Clinical Stage Anti-PS Antibody Bavituximab

Peregrine's clinical stage PS-targeting antibody bavituximab binds to the cellular membrane component phosphatidylserine (PS) that is usually located inside cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. By binding to PS, bavituximab is believed to help mobilize the body's immune system to destroy the tumor and the tumor blood vessels. Bavituximab currently is in two separate Phase II combination therapy trials for the treatment of advanced breast cancer and a Phase II combination therapy trial for the treatment of non-small
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
4. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
5. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
6. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
7. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
8. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
9. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
10. Oridion Announces Significant Medical Studies Presented at STA
11. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... FORT COLLINS, Colo., Dec. 14 Manchester ... 250 mg (chenodiol tablets). On October 22, ... approved Chenodal, an important therapy for patients suffering ... health risk due to disease or advanced age. ... to patients exclusively through Centric Health Resources ("Centric"), ...
(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 Travelers of Interstate 70 ... has become a bit more colorful when 10 multicolored ... which is named going home , will eventually ... Armstrong, a graduate student at Herron School of Art ... and Public Life. ,, Eli Lilly and Company ...
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
Breaking Medicine Technology:Manchester Announces Availability of Chenodal(TM) 2Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco 60153 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 2Soligenix to Present at 8th Annual BIO Investor Forum 14615 1Soligenix to Present at 8th Annual BIO Investor Forum 14615 2Soligenix to Present at 8th Annual BIO Investor Forum 14615 3Soligenix to Present at 8th Annual BIO Investor Forum 14615 4
(Date:12/14/2009)... up 900-Member Physician Staff , ... La Jolla, Calif. ... elected Marc Sedwitz, MD, as the new chief of staff of ... the 900-member physician team on Jan. 1, 2010. , , , ... staff liaison to Scripps La Jolla’s administrative staff and its board ...
(Date:12/14/2009)... Tens of Thousands of New Chronic Hepatitis Infections ... Legislation approved by Congress providing for federal funding ... to reduce tens of thousands of new viral ... States, the National Viral Hepatitis Roundtable ... in the FY 2010 Consolidated Appropriations bill approved ...
(Date:12/14/2009)... BOSTON, Dec. 14 When Kurth Krause, ... crew instructions for landing on the moon, he,was ... about anything.,Years later, Kurth realized there was one ... a kidney transplant and even though dialysis machines,would ... without a transplant. Kurth,wrote: "My wife is 69 ...
(Date:12/14/2009)... some protection, study finds, , , MONDAY, Dec. 14 (HealthDay ... start their morning without a cup or two of ... of developing type 2 diabetes. , That,s the ... more coffee you drink, the lower your risk of ... 7 percent reduction in the risk of diabetes, the ...
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... and warning alerts via Drugs.com and Google Health , ... 24 Drugs.com, the leading online resource for information ... the launch of a new online tool that will ... own medications, to ultimately help reduce dangerous side effects ...
... Forecaster, Medicare shoppers can compare and enroll in many ... NEW YORK, Nov. 24 The day after ... shopping rush. For seniors and their families who need ... to "shop" for coverage using the award-winning bWell-informed(TM) Health ...
... Florida’s Natural Growers was held at the Lake ... November. The theme of this year’s meeting, “Growing ... Cooperative reported one of the highest Orange Returns ... environment. In fact, Chairman Dick Fort stated, “When ...
... Arlene Bardeguez, MD, MPH: , The majority of the one ... or rely on public programs for care. As the ... strain on publicly funded programs will only grow. ... yet know they are infected. Most won,t be diagnosed until ...
... (NYSE: CVD ) is pleased to invite you to listen to its ... 18, 2008 at 9:00 a.m. ET. , , , ... Webcast and slide presentation, When: ... http://www.covance.com , , , Covance, with ...
... low self-esteem, poor relationships with parents, and low academic achievement ... young people having sex before the age of 15. Alternatively, ... reduce risky sexual behavior during adolescence, according to Myeshia Price ... the USA. Their findings have just been published online in ...
Other Medicine News:Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 2Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 3Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 4Health News:Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions 5Health News:bWell-informed(TM) Adds Medicare Plan Tools for 2008 Open Enrollment Season 2Health News: Florida's Natural Celebrates 75 Years with Record Performance 2Health News: Florida's Natural Celebrates 75 Years with Record Performance 3Health News:World AIDS Day: Dec. 1, 2008 2Health News:TV: Not the only channel to early sex 2
... The Given system, developed by Given Imaging of ... size of a grape. Weighing in at only ... camera, 4 LED lights, battery and radio transmitter ... resistant to digestive enzymes. Internal gastric images are ...
... The catheter-free Bravo pH Monitoring ... pH testing is done. Bravo ... regular diet and activities during ... is catheter-free, the added convenience ...
... CO2 TMR technology is an ... diffuse vessels with poor targets. ... between surgical suites, the CO2 ... surgeon to make timely operative ...
... highly accurate & lightweight system utilizing state ... capacity that can take extensive measurements over ... measurement intervals from 5 to 60 minutes. ... configuration, data collection and analysis. Easy ...
Medicine Products: